DANCIBRA, created in 2013 (United States), from
61 sister brands
and 17479 competing brands.
The DANCIBRA brand is owned by Biogen Idec, a company listed in New York.
The sector of DANCIBRA is Drug Manufacturers.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.